http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2004098713-A3

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_d829238b6ff7027e0e8106443ccdbfbb
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_9e685096ab0ccdbfb3f427d583fcdb84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_2ca2e4410855da087e11bf3eea8933fa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_13e97e96d8b192ca93625870011337f1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f5def80d000c45e4f0989f2d8281d0e7
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4365
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-60
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4743
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P9-04
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4365
filingDate 2004-04-26-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_dd0cede0d9d89fc883aa609169663113
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d8fb711ff14ba29e3edd872d4b0cc2f6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_23c2f25c32c806f259481a9b2e1e27ab
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_87608fadde0a9fb65e412809e701938a
publicationDate 2004-12-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber WO-2004098713-A3
titleOfInvention Treating cardiovascular diseases with a compound of formula (i) (cs 747 - prasugrel; rn 150322-43-4)
abstract A method of treating Cardiovascular Diseases comprising administering of a compound of formula (I) (chemical names i.a. CS747 or Prasugrel; registry number 150322-43-3) or a pharmaceutically acceptable salt, solvate, prodrug, active metabolite, racemate or enantiomer thereof, in conjunction with coronary and non-coronary intervention procedures is disclosed.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-9125945-B2
priorityDate 2003-05-05-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-9749397-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0144239-A2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0204461-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1298132-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02051412-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID51371330
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6918456
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419480215
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226396335

Total number of triples: 39.